research

Webinar Topic: In this episode, Trevor will be joined by CPA (Canadian Psychedelic Association) Board Member Jazmin Pirozek to discuss what the CPA is and what role is seeks to serve in the psychedelic space.Bios:Trevor Millar is a social-entrepreneur and owner of Liberty Root Therapy Ltd., a business dedicated to healing and transformation using the anti-addictive plant medicine ibogaine and other psychedelic compounds. Trevor currently serves as Board Chair for the Multidisciplinary Association of Psychedelic Studies (MAPS) Canada and is a former Executive Director of the Global Ibogaine Therapy Alliance. Featured in the award-winning documentary about using magic mushrooms and Iboga to heal addiction, anxiety and depression called DOSED, he is also a founding member of the newly formed Canadian Psychedelic Association.Jazmin Pirozek HBA, MSc practices and teaches traditional and contemporary methods regarding plants of the Boreal and Amazon forests. Currently, Jazmin is a consultant combining scientific and traditional methods, focusing on remediating chronic illnesses for the people of Northern Ontario, Canada. Jazmin has applied concepts of Nishnawbe Aski Nation Health Transformation perspectives in her work to combine Traditional and Contemporary Health practices to create better access to Integrative medicine for all. Jazmin founded Boom Bay Integrative Healing and Learning Centre on Beautiful Lake of the Woods, Kenora, Ontario, which is set to continue construction into 2021.————————-Examining the Psychedelic Renaissance Season 2: About The SeriesWe are in the middle of the psychedelic renaissance. With research projects and decriminalization proposals popping up across North America and with MDMA on the verge of approval as a treatment for PTSD, psychedelic therapy is on track to become the next major breakthrough in mental health care.MAPS Canada has supported studies to develop psychedelics into safe and legal medical treatments since its formation in 2008. Currently, MAPS Canada is funding two separate studies on MDMA and cognitive processing therapy as a treatment for PTSD. Additionally, plans to fund studies that identify psychedelic treatments for eating disorders and others that involve Ibogaine are in the works.To conduct and publish scientific research and education supporting the beneficial use of psychedelic medicines, MAPS Canada relies on public donations and fundraising initiatives. To support its mission MAPS Canada is launching a new webinar series, entitled “Examining The Psychedelic Renaissance”.————————-Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.Learn More at https://mapscanada.org/about/MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/Many ways to engage, join our community:https://twitter.com/mapscanadahttps://www.instagram.com/mapscanada/https://www.facebook.com/MAPSCanada/#MAPSCanada #Psychedelic #Research #Medicine #Therapy